Loading company…
Vaccibody is an Oslo, Norway biotechnology company developing immunotherapy for cancer based on its Vaccibody molecule platform.
Founded in 2006 in Oslo, Norway, Vaccibody develops immunotherapy treatments, mainly for cancer, based on its Vaccibody molecule. The company has completed six deals, the most recent a EUR 0.730 mn round on June 21, 2013, and its CEO is Michael Engsig. It reported revenue of EUR 12.90 mn and EBITDA of EUR -54.53 mn for fiscal 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in